1. Introduction {#sec1}
===============

Previous studies revealed that cardiovascular diseases (CVD) begin in childhood \[[@B1], [@B2]\], and endothelial damage may occur early in the life of children with lipid abnormalities \[[@B3], [@B4]\]. The Cardiovascular Risk in Young Finns Study \[[@B5]\] showed a positive correlation between the number of risk factors at age12--18 years and carotid artery wall thickness at age 33--39 years. Furthermore, Morrison et al. \[[@B6]\] showed that the metabolic syndrome (MeS) in childhood predicts MeS and type 2 diabetes mellitus in adulthood.

While earlier studies in childhood had focused on the clustering of risk factors for cardiovascular diseases \[[@B7], [@B8]\], recent studies had reported the prevalence of MeS during childhood \[[@B9]--[@B11]\]. Several definitions have been proposed for MeS in children and some of these definitions followed the ATP III guidelines \[[@B9]--[@B14]\]. The International Diabetes Federation (IDF) consensus worldwide definition of the MeS is divided according to age-groups because of developmental challenges presented by age-related differences in children and adolescents: 6 --\<10 years, 10 --\<16 years, and ≥16 years \[[@B15], [@B16]\].

The prevalence of the MeS varied by the definition used, the weight status of the children, sex, and ethnicity. Cook et al. \[[@B9]\] reported a prevalence of 4.2% among children and adolescents of 12--19 years of age using the third National Health and Nutrition Examination Survey (NHANES III) data. A prevalence of 3.6% in youth 8--17 years of age was reported by researchers from the Bogalusa Heart Study \[[@B17]\]. Much higher prevalence rates were reported in children who were overweight or obese \[[@B9], [@B13]\], where the prevalence reached 50% in severely obese youngsters \[[@B13]\].

Data pertaining to MeS in children are scarce and most studies were conducted in developed countries with very little is known about this syndrome in children in the middle east and Arab countries including Jordan. Therefore, this study aimed to determine the prevalence of MeS and its individual components in Jordanian children and adolescents aged 7--18 years and determine the factors that are associated with clustering of metabolic abnormalities.

2. Methods {#sec2}
==========

2.1. Sampling {#sec2.1}
-------------

A national population-based household sample was selected from the 12 governorates of Jordan. These 12 governorates belong to the three regions of the country, namely, the north, middle, and south. A complex multistage sampling technique was used to select the households, taking into consideration the geographic distribution of the population as well as the urban-rural residence. As the population is covered by an extensive network of health centers and because the study procedures have to take place in a medical setting, the selection of households was health center-oriented. The health director in each governorate was contacted and asked to identify at least two health centers in which to conduct the study procedures. He was asked to select the health centers so that urban and rural areas in each governorate are represented and the selected centers have enough space to host the study team, participants, and equipments. A total of 31 health centers were identified and people served by these centers were targeted. A systematic sample of households was selected from the population served by the selected health centers. The number of selected households was approximately proportional to the population in each region.

In each selected area, one day before data collection, 2-membered teams (a male and a female each) visited the selected households, explained the purpose of the study, and invited all members aged ≥7 years, who were available at the time of visit, to attend the health centre in the next day after an overnight fast. Subjects on regular medications were asked not to take their medications early at that day and to bring all their medications with them to the survey site. To encourage participation, the study team worked in all week days including official holidays except Fridays during the entire study period. Of the 1600 families invited to participate, 1282 (80.1%) families (5640 subjects aged between 7 and 90 years) took part in this study. Of the total 1290 children and adolescents (aged 18 years or less) who were invited to participate, 1046 (81.1%) subjects responded and participated in the study.

2.2. Data Collection {#sec2.2}
--------------------

All field work was carried out between 1st of July and 30th of November, 2009. Participants attended the health centers in the morning (8--11 am) with a minimum fasting time of 10 hours. A pilot-tested structured questionnaire was prepared and administered by trained interviewers to collect relevant information that is necessary to answer the current research question and other selected research questions that will be addressed in separate publications. The questionnaire sought information on demographics, medical history and medication use, level of education, average monthly family income, and amount of exercise per week. Information on other variables necessary for other research questions was collected. Two questions related to physical activity were modified from the Leisure Time Exercise Questionnaire to assess the physical activity of participants \[[@B18]\]. The two questions individually assessed moderate and vigorous activity asking, "In the past week, how many hours did you spend doing moderate activity\" and "In the past week, how many hours did you spend doing vigorous activity\". More than 10 examples of common specific activities were given after each question.

2.3. Measurements and Laboratory Analysis {#sec2.3}
-----------------------------------------

Anthropometric measurements including weight, height, waist, and hip circumferences were measured with the subjects wearing light clothing and no shoes. Height and weight were determined to the nearest 0.1 cm. WC was measured to the nearest centimeter using nonstretchable tailors measuring tape at the midpoint between the bottom of the rib cage and above the top of the iliac crest during minimal respiration. Hip circumference was measured at the widest part of the body below the waist. Readings of systolic (SBP) and diastolic blood pressure (DBP) were taken in duplicates with the subject seated and the arm at heart level, after at least 5 minutes of rest, using standardized mercury sphygmomanometer with appropriate arm cuff length. The mean of these two determinations was used to express the individual\'s systolic and diastolic blood pressures.

For laboratory analysis and all biochemical measurements, two sets of fasting blood samples were drawn from a cannula inserted into the antecubital vein into sodium fluoride potassium oxalate tubes for glucose and lithium heparin vacuum tubes for lipids. Samples were centrifuged at 3000 rpm for 10 min within 1 hour at the survey site, and plasma was transferred to separate labeled tubes and transferred immediately in cold boxes filled with ice to the central laboratory of the National Center for diabetes and endocrinology. All biochemical measurements were carried out by the same team of laboratory technicians and the same method throughout the study period.

Triglycerides values were obtained on COBAS INTEGRA 700 with the cassette COBAS INTEGRA Triglycerides using enzymatic, colorimetric method (GPO/PAP) with glycerol phosphate oxidase and 4-aminophenazone. Total cholesterol was analyzed using enzymatic, colorimetric method with COBAS INTEGRA Cholesterol Gen.2. HDL cholesterol and LDL cholesterol values were obtained on COBAS INTEGRA 700 using homogeneous enzymatic colorimetric assay. Other laboratory analysis was also performed for several blood constituents, but it is not described here because they are irrelevant to the current report.

2.4. Definition of Variables {#sec2.4}
----------------------------

To define MeS according to IDF definition, age was divided into three groups: 7 to \<10 years, 10 to \<16, and 16 years and older. The MeS was not diagnosed in children younger than 10 years old as stated in the IDF definition \[[@B15], [@B16]\]. For children aged between 10 and 15 years, a diagnosis of the MeS was made as the presence of abdominal obesity (WC ≥90th percentile or adult cut-off if lower) and the presence of two or more of the other components: Elevated TG (≥1.7 mmol/L (≥150 mg/dL)), low HDL cholesterol (\<1.03 mmol/L (\<40 mg/dL)), high blood pressure (Systolic ≥130 mm Hg or diastolic ≥85 mm Hg), and elevated blood glucose (≥5.6 mmol/L (100 mg/dL)). IDF criteria for adults \[[@B19]\] were used to define MeS in those aged 16 years or more. Although that the MeS was not diagnosed for children younger than 10 years, other components were defined, for all subjects who had complete information on that component, as those for children aged between 10 and 15 years. Of children and adolescents selected, 10 subjects had missing information on at least one of the anthropometric measures, blood pressure measurements, and lipid measurements. However, only 671 subjects had blood glucose measurements. MeS was defined and reported for subjects aged 10 years or more who had complete information on all components of MeS (*n* = 512).

Body mass index (BMI) was calculated as the ratio of weight in kilograms to the square of height in meters, and then standardized for sex and age using data from the Center for Disease Control and Prevention (USA) \[[@B20]\]. Overweight was defined as a BMI between the 85th and 95th percentiles, and obesity as a BMI greater than or equal to the 95th percentile \[[@B21]\].

2.5. Data Management and Statistical Analysis {#sec2.5}
---------------------------------------------

Data were entered into computer using the Statistical Package for Social Sciences software, SPSS (SPSS Inc., Chicago, IL, USA) version 15. Participants\' characteristics were described using means, standard deviations, and percentages wherever appropriate. The differences between percentages were analyzed using **χ**^2^ test, and the differences between two means were analyzed using independent sample *t*-test. Multivariable logistic regression models were fit to determine factors associated with various clustering of CVD risk factors (outcome variables): at least one metabolic abnormality, at least two metabolic abnormalities, and at least three metabolic abnormalities. Logistic regression was conducted using backward stepwise elimination method to reach the "best fitting model\" that includes the significant variables only. Similar analysis was repeated for each outcome variable. A *P*-value of less than  .05 was considered statistically significant.

3. Results {#sec3}
==========

3.1. Participants\' Characteristics {#sec3.1}
-----------------------------------

This study included a total of 1046 subjects (478 boys and 568 girls) aged between 7 and 18 years with a mean of 12.5 (3.2) year. [Figure 1](#fig1){ref-type="fig"} shows the age distribution for boys and girls. About 46.7% of subjects were living in the north, 43.5% in the middle, and 9.8% in the south of Jordan. [Table 1](#tab1){ref-type="table"} shows their anthropometric, lipid profile, and clinical characteristics according to age and gender.

3.2. The Prevalence of MeS {#sec3.2}
--------------------------

The prevalence of MeS according to IDF criteria was estimated from 512 subjects (235 boys, 277 girls, 345 aged 10--15.9 years and 167 aged 16--18 years) who had complete information on all MeS components. The prevalence of MeS according to IDF criteria was 1.4% in subjects aged between 10 and 15.9 years (1.1% for boys and 1.9% for girls, *P*-value =.556) and 3.6% in subjects aged between 16 and 18 years (3.8% for boys and 3.5% for girls, *P*-value =.906) ([Figure 2](#fig2){ref-type="fig"}). There was no significant difference in the prevalence of MeS between the two age groups (*P*-value =.117) and between boys and girls in both age groups.

When categorized according to BMI category, the prevalence of the MeS was 15.1% in obese subjects, compared to 0.3% in subjects with normal BMI (BMI \< 85th percentile) and 3.0% in overweight subjects.

3.3. The Prevalence of Individual Metabolic Abnormalities {#sec3.3}
---------------------------------------------------------

In the whole sample, the most commonly found abnormality was low HDL cholesterol (26.1%) followed by high TG (17.2%). The prevalence rates were 7.2% for high fasting glucose, 6.2% for high blood pressure, and 5.8% for increased waist circumference. About 44.4% had at least one metabolic abnormality, 16.1% had at least two metabolic abnormalities, and 4.2% had at least three metabolic abnormalities. The prevalence of clustering of metabolic abnormalities according to BMI is shown in [Figure 3](#fig3){ref-type="fig"}.

[Table 2](#tab2){ref-type="table"} shows the prevalence of individual metabolic abnormalities for boys and girls according to age. The prevalence for children aged ≤12 and \>12 years, respectively, was 3.2% and 8.0% for high blood pressure, 14.6% and 18.9% for high TG levels, 20.5% and 29.6% for low HDL levels, and 3.7% and 7.1% for increased waist circumference. The prevalence of at least one CVD risk factors was 36.5% and 49.3%, respectively. The prevalence of obesity (waist circumference), low HDL cholesterol, high blood pressure, at least one metabolic abnormality, and at least three metabolic abnormalities were significantly higher among subjects aged \> 12 years compared to those among subjects aged ≤12 years.

3.4. Factors Associated with Clustering of MeS Components {#sec3.4}
---------------------------------------------------------

MeS was significantly associated with BMI only. None of other variables were significantly associated with MeS. Children with overweight were 12.2 times more likely to have MeS (*P*-value =.042), and those with obesity were 69.5 times more likely to have MeS (*P*-value \<.005).

[Table 3](#tab3){ref-type="table"} shows the factors that are associated with the three outcome variables: having at least one metabolic abnormality, having at least two metabolic abnormalities, and having at least three metabolic abnormalities. Compared to children aged ≤12 year, those who were older than 12 years had higher odds of having at least one metabolic abnormality (OR = 1.6) and having at least two metabolic abnormalities (OR = 17.2). Children living in north (OR = 2.3) and middle (OR = 2.6) were more likely to have at least one metabolic abnormality. Compared to those with normal BMI, children with obesity had higher odds of having at least one, two, or three metabolic abnormalities. Children with overweight were more likely to have at least one metabolic abnormality only. Exercise for more than 7 hours per week was associated with decreased odds of having at least three metabolic abnormalities.

4. Discussion {#sec4}
=============

Only few studies have assessed the prevalence of MeS in a population-based samples of young people \[[@B9], [@B22]--[@B24]\]. Although direct comparison across studies is difficult because of the differences in the definition of the syndrome, the overall prevalence of MeS in Jordanian children and adolescents (2.1%) was similar to that reported in subjects aged from 10 to 17 years in Turkey (2.2%) \[[@B25]\]. Using a definition similar to that proposed in ATP III criteria, a prevalence of 4.2% was reported among US adolescents aged 12 to 19 years who participated in the NHANES III \[[@B9]\]. Using the 2007 pediatric IDF definition among US adolescents aged 12--17 years, Ford et al. reported that the prevalence of the MeS was approximately 4.5% \[[@B24]\]. In northern Mexico children and adolescents aged 10--18 years, the prevalence varied between 3.8% to 7.8% according to the definition used \[[@B10]\]. Much higher prevalence rates were reported in Kuwaiti female adolescents aged 10--19 years, where the prevalence was 14.8% using IDF and 9.1% using the ATP III modified for age diagnostic criteria \[[@B26]\]. Furthermore, a prevalence of 9.2% was reported in subjects aged 12--19 years in Korea \[[@B27]\].

Although some of the previous studies suggest that the overall prevalence rates of the MeS in childhood are low, the perspective is very different in overweight and obese adolescents. In this study, the prevalence of the MeS was 0.3% in subjects with normal BMI, 3.0% in overweight subjects, and 15.1% in obese subjects. This finding is similar to that reported by others who reported that the prevalence is much higher among obese children and adolescents. In some studies, the prevalence approximated 30%--50% among obese children and adolescents \[[@B9], [@B13], [@B25], [@B27]--[@B29]\].

In the whole sample, the most commonly found abnormality was low HDL (26.1%) followed by increased TG (17.2%). In contrast, the prevalence rates were 7.2% for high fasting glucose, 6.2% for high blood pressure, and 5.8% for increased waist circumference. In US adolescents, the most common abnormality was high triglycerides and low HDL cholesterol \[[@B9]\]. In the same study, the prevalence rate of high fasting glucose was very low (1.5%).

In our study, BMI defined obesity was significantly associated with increased odds of clustering of metabolic abnormalities in the multivariate analysis. The role of obesity and insulin resistance in the etiology of the metabolic syndrome has been explored in children in other studies \[[@B14], [@B30]\]. Our finding is in agreement with that reported by others \[[@B31], [@B32]\]. Chu et al. \[[@B31]\] reported that the prevalence of two or more cardiovascular risk factors was four to five times greater in obese than in nonobese children.

Having regular physical activity of more than 7 hours per week was associated with lower odds of MeS. Low levels of physical activity were identified in other studies as a potential modifiable factor associated with metabolic risk in children, and habitual physical activity and aerobic fitness were shown to be inversely associated with the MeS score \[[@B33]--[@B35]\]. This association was shown in some studies to be independent of adiposity \[[@B36], [@B37]\].

This study showed that subjects living in the north or middle regions were more likely to have MeS compared to those living in the south. This finding might be explained by the differences in the socioeconomic and nutrition status between the three regions of Jordan. Previous reports supported the association between socioeconomic status and the MeS among children, and the potential mechanisms suggested were low birthweight, poor nutrition, and inadequate physical activity \[[@B38], [@B39]\].

The associations between studied variables and MeS should be interpreted with cautious since we cannot infer causality from our findings because this study is cross-sectional and some studied variables such as physical activity were self-reported.

In conclusion, our results indicate that although the prevalence of MeS is low in Jordanian children and adolescents, a large proportion of them had one or two metabolic abnormalities.

![The age distribution of Jordanian 478 boys and 568 girls aged between 7 and 18 years.](IJPE2010-316170.001){#fig1}

![The prevalence of metabolic syndrome among boys and girls using the International Diabetes Federation (IDF) consensus worldwide definition according to the age group (10--\<16 year and 16--18 year).](IJPE2010-316170.002){#fig2}

![The prevalence of clustering of metabolic abnormalities among Jordanian children and adolescent aged between 7 and 18 years according to body mass index.](IJPE2010-316170.003){#fig3}

###### 

Anthropometric, lipid profile, and clinical characteristics for boys and girls according to age.

                                  Boys   Girls                                                                                  
  ------------------------------- ------ -------------- ----- -------------- -------- ----- -------------- ----- -------------- --------
  Weight (Kg)                     190    28.3 (8.3)     283   52.1 (15.5)    \<.005   208   29.8 (10.0)    357   52.0 (13.2)    \<.005
  Weight *Z* score                190    −0.81 (0.48)   283   0.54 (0.88)    \<.005   208   −0.87 (0.62)   357   0.50 (0.82)    \<.005
  Height (cm)                     190    130.1 (9.3)    238   157.0 (13.0)   \<.005   208   131.3 (10.3)   357   154.7 (7.3)    \<.005
  Height *Z* score                190    −0.91 (0.53)   283   0.61 (0.74)    \<.005   208   −1.04 (0.73)   357   0.61 (0.52)    \<.005
  Body mass index (BMI) Kg/m^2^   190    16.5 (3.3)     283   20.8 (4.56)    \<.005   208   16.9 (3.5)     357   21.6 (4.5)     \<.005
  BMI *Z* score                   190    −0.56 (0.73)   283   0.38 (0.98)    \<.005   208   −0.62 (0.73)   357   0.36 (0.96)    \<.005
  Waist circumference (cm)        193    55.7 (7.9)     283   68.9 (10.8)    \<.005   209   56.5 (8.3)     356   67.3 (8.7)     \<.005
  Hip circumference (cm)          193    68.1 (7.8)     282   86.4 (11.0)    \<.005   210   71.4 (9.5)     356   90.9 (11.0)    \<.005
  Systolic blood pressure         193    101.4 (9.6)    283   110.0 (12.2)   \<.005   210   101.1 (12.1)   355   108.5 (9.8)    \<.005
  Diastolic blood pressure        193    66.4 (8.1)     282   70.7 (9.3)     \<.005   210   66.4 (9.3)     355   71.5 (8.1)     \<.005
  Total cholesterol (mg/dL)       195    164.1 (31.7)   283   159.0 (34.1)   .099     210   166.5 (32.9)   358   163.8 (31.6)   .323
  HDL cholesterol (mg/dL)         195    52.1 (13.9)    283   45.3 (13.0)    \<.005   210   49.9 (11.8)    358   48.4 (12.1)    .167
  LDL cholesterol (mg/dL)         195    90.1 (26.7)    283   86.6 (27.8)    .170     210   92.7 (27.7)    358   89.7 (25.7)    .189
  Triglyceride (mg/dL)            195    96.8 (58.9)    283   113.8 (62.0)   .003     210   111.8 (61.6)   358   109.4 (52.7)   .618
  Fasting blood glucose (mg/dL)   123    85.5 (10.4)    175   87.3 (18.8)    .320     134   81.1 (10.2)    239   83.8 (15.2)    .062

###### 

The prevalence of individual metabolic abnormalities for boys and girls according to age.

  -------------------------------------------------------------------------------------------------------------
                          Age (year)                                                                     
  ----------------------- ------------ ------------ ------------ ------------ ------------- ------------ ------
  Abdominal obesity                                                                                      .025

   Yes                    4 (2.1)      11 (5.3)     15 (3.7)     16 (5.7)     29 (8.2)      45 (7.1)     

   No                     189 (97.9)   197 (94.7)   386 (96.3)   266 (94.3)   325 (91.8)    591 (92.9)   

  Triglycerides level                                                                                    .072

   High                   22 (11.3)    37 (17.6)    59 (14.6)    57 (20.1)    64 (17.9)     121 (18.9)   

   Normal                 173 (88.7)   173 (82.4)   346 (85.4)   226 (79.9)   294 (82.1)    520 (81.1)   

  HDL cholesterol                                                                                        .001

   Low                    42 (21.5)    41 (19.5)    83 (20.5)    100 (35.3)   90 (25.1)\*   190 (29.6)   

   Normal                 153 (78.5)   169 (80.5)   322 (79.5)   183 (64.7)   268 (74.9)    451 (70.4)   

  Blood pressure                                                                                         .002

   High                   5 (2.6)      8 (3.8)      13 (3.2)     34 (12.1)    17 (4.8)\*    51 (8.0)     

   Normal                 188 (97.4)   202 (96.2)   390 (96.8)   248 (87.9)   337 (95.2)    585 (92.0)   

  Fasting blood glucose                                                                                  .462

   Elevated               10 (8.1)     6 (4.5)      16 (6.2)     14 (8.0)     18 (7.5)      32 (7.7)     

   Normal                 113 (91.9)   128 (95.5)   241 (93.8)   161 (92.0)   221 (92.5)    382 (92.3)   

  Number of metabolic\                                                                                   
  abnormalities                                                                                          

   0                      73 (59.3)    89 (67.4)    162 (63.5)   79 (45.1)    129 (54.9)    208 (50.7)   .001

   ≥1                     50 (40.7)    43 (32.6)    93 (36.5)    96 (54.9)    106 (45.1)    202 (49.3)   .001

   ≥2                     12 (9.8)     22 (16.7)    34 (13.3)    38 (21.7)    35 (14.9)     73 (17.8)    .127

   ≥3                     0 (0)        2 (1.5)      2 (0.8)      17 (9.7)     9 (3.8)\*     26 (6.3)     .001
  -------------------------------------------------------------------------------------------------------------

\*Indicates a statistically significant difference between boys and girls within age group.

###### 

Multivariate analysis of factors associated with having at least one metabolic abnormality, having at least two metabolic abnormalities, and having at least three metabolic abnormalities.

                       ≥1 component      ≥2 components   ≥3 components                                 
  -------------------- ----------------- --------------- ----------------- -------- ------------------ --------
   ≤12                 1                                                            1                  
   \>12                1.6 (1.1, 2.4)    .010                                       17.2 (2.2, 30.7)   .006
  Body mass index                                                                                      
   Normal              1                                                                               
   Overweight          2.2 (1.3, 3.7)    .005            1.8 (0.9, 3.5)    .083     1.3 (0.3, 4.7)     .727
   Obesity             7.4 (3.6, 15.4)   \<.005          6.2 (3.4, 11.4)   \<.005   6.7 (2.6, 17.5)    \<.005
  Region                                                                                               
   North               2.3 (1.4, 3.7)    \<.005                                                        
   Middle              2.6 (1.4, 4.6)    .002                                                          
   South               1                                                                               
  Regular activities                                                                                   
   ≤7 hours/week                                                                    1                  
   \>7 hours/week                                                                   0.3 (0.1, 0.8)     .013
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